Company page
Berry Genomics Co. Ltd. Class A
Berry Genomics Co. Ltd. Class A, traded under the ticker 000710, is a public company based in China with a market capitalization of approximately 409.15 million USD. The company specializes in genomic testing and related services, contributing to advancements in precision medicine. Berry Genomics aims to enhance healthcare outcomes through innovative genomic solutions.
- Ticker
- 000710:SZSE
- Asset type
- Stock
- Market cap
- $409.2M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- SZSE
- Currency
- CNY